Association of Lp(a) Levels With Changes in Coronary Atherosclerosis in Patients Treated With Alirocumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Association of Lipoprotein(a) With Changes in Coronary Atherosclerosis in Patients Treated With Alirocumab
Circ Cardiovasc Imaging 2024 Nov 01;17(11)e016683, KC Koskinas, J Häner, Y Ueki, T Otsuka, J Lonborg, H Shibutani, R Kakizaki, C Kaiser, RJ van Geuns, AS Ondracek, F Praz, M Ambühl, D Spirk, J Lanz, J Daemen, D Heg, M Mayr, F Mach, S Windecker, T Engstrøm, IM Lang, A von Eckardstein, S Losdat, L RäberFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.